Published August 2017 | Version v1
Journal article Metadata-only

Therapy assessment in prostate cancer using choline and PSMA PET/CT

Creators

  • 1. University of Bologna, Nuclear Medicine Unit, S. Orsola-Malpighi University Hospital, Bologna (Italy)
  • 2. University of California Los Angeles, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, Los Angeles, CA (United States)
  • 3. University Hospital Essen, Department of Nuclear Medicine, Essen (Germany)
  • 4. University Hospital Essen, Department of Urology, Essen (Germany)

Description

While PET with non-FDG tracers (mainly choline and Ga-PSMA) has commonly been used for restaging in men with biochemically recurrent prostate cancer, as well as for primary staging, it is only recently that a few preliminary studies have addressed the possible use of PET for monitoring the response to systemic therapy of metastatic disease, especially innovative treatments such as abiraterone and enzalutamide. This article aims to evaluate the role of PET imaging with different non-FDG radiotracers for assessment of therapy in advanced prostate cancer patients. (orig.)

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-017-3723-3

Additional details

Identifiers

DOI
10.1007/s00259-017-3723-3;

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
44
Journal Issue
Suppl.1
Series
Special issue on Therapy assessment with PET in cancer patients
Journal Page Range
p. 78-83
ISSN
1619-7070
CODEN
EJNMA6

INIS

Country of Publication
Germany
Country of Input or Organization
Germany
INIS RN
48084204
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
ANDROGENS; ANTIGENS; CARCINOMAS; CASTRATION; CELL CULTURES; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC USES; FLUORINE 18; GALLIUM 68; METASTASES; MONITORING; POSITRON COMPUTED TOMOGRAPHY; PROSTATE; RADIOPHARMACEUTICALS; SURVIVAL CURVES; SURVIVAL TIME; UPTAKE
Descriptors DEC
ANDROSTANES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELECTRON CAPTURE RADIOISOTOPES; EMISSION COMPUTED TOMOGRAPHY; FLUORINE ISOTOPES; GALLIUM ISOTOPES; GLANDS; HORMONES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MALE GENITALS; MATERIALS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANIC COMPOUNDS; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; STEROID HORMONES; STEROIDS; SURGERY; THERAPY; TOMOGRAPHY; USES